ABL Bio Launches Clinical Collaboration to Assess ABL103 with KEYTRUDA in Solid Tumor Patients Read more
Gilead Partners with Six Generic Manufacturers for Royalty-Free Licensing to Boost Lenacapavir Access for HIV Prevention in Resource-Limited Countries Read more
GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies Read more
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America Read more
Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease Read more
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities Read more
Phare Bio Secures Up to $27 Million from ARPA-H to Propel AI-Driven Drug Discovery and Innovate New Antibiotics Read more
Tempus Expands Partnership with Takeda to Enhance Oncology Research Using Multimodal Real-World Data and Biological Models Read more